News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Yale Catriona
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 591 shares
@ $55.16, valued at
$32.6k
|
|
| 03/14/2023 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 701 shares
@ $43.46, valued at
$30.5k
|
|
| 01/18/2023 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 1,048 shares
@ $49.1187, valued at
$51.5k
Sold 1,534 shares
@ $49.8901, valued at
$76.5k
Sold 1,313 shares
@ $51.1784, valued at
$67.2k
Sold 1,105 shares
@ $51.987, valued at
$57.4k
|
|
| 12/20/2022 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 29,073 options to buy
@ $21.1, valued at
$613.4k
|
|
| 12/13/2022 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 19,195 shares
@ $0
Sold 4,598 shares
@ $43.18, valued at
$198.5k
Sold 402 shares
@ $43.77, valued at
$17.6k
Granted 86,379 options to buy
@ $42.95, valued at
$3.7M
|
|
| 11/14/2022 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 4,900 shares
@ $39.41, valued at
$193.1k
Sold 100 shares
@ $39.96, valued at
$4k
|
|
| 10/12/2022 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $37.99, valued at
$190k
|
|
| 09/15/2022 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 26,014 shares
@ $27.18, valued at
$707.1k
Sold 13,986 shares
@ $28.04, valued at
$392.2k
|
|
| 09/13/2022 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,152 shares
@ $8.03, valued at
$9.3k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
|
|
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $20.9044, valued at
$209k
|
|
| 12/09/2020 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,245 shares
@ $17.068, valued at
$21.2k
Granted 77,580 options to buy
@ $28.35, valued at
$2.2M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $21.09, valued at
$1.8M
|
|
| 06/19/2019 |
3
| Yale Catriona (Chief Development Officer) has filed a Form 3 on Akero Therapeutics, Inc. |
|
|